172 related articles for article (PubMed ID: 17982751)
1. Polymorphisms in genes related to activation or detoxification of carcinogens might interact with smoking to increase renal cancer risk: results from The Netherlands Cohort Study on diet and cancer.
Smits KM; Schouten LJ; van Dijk BA; van Houwelingen K; Hulsbergen-van de Kaa CA; Kiemeney LA; Goldbohm RA; Oosterwijk E; van den Brandt PA
World J Urol; 2008 Feb; 26(1):103-10. PubMed ID: 17982751
[TBL] [Abstract][Full Text] [Related]
2. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
[TBL] [Abstract][Full Text] [Related]
3. Glutathione S-transferase M1, T1, and P1 polymorphisms as risk factors for renal cell carcinoma: a case-control study.
Sweeney C; Farrow DC; Schwartz SM; Eaton DL; Checkoway H; Vaughan TL
Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):449-54. PubMed ID: 10794492
[TBL] [Abstract][Full Text] [Related]
4. Risk of renal cell carcinoma and polymorphism in phase I xenobiotic metabolizing CYP1A1 and CYP2D6 enzymes.
Ahmad ST; Arjumand W; Seth A; Nafees S; Rashid S; Ali N; Hamiza OO; Sultana S
Urol Oncol; 2013 Oct; 31(7):1350-7. PubMed ID: 22281432
[TBL] [Abstract][Full Text] [Related]
5. [Prevention of renal carcinoma: the nutri-genetic approach].
Junien C; Dupret JM; Gallou C; Longuemaux S; Richard S; Saquet C; Krishnamoorty R; Delomenie C; Droz D; Bouvier R; Chauveau D; Joly D; Grunfeld JP; Chretien Y; Mejean A; Beroud C
J Soc Biol; 2000; 194(1):29-38. PubMed ID: 11107547
[TBL] [Abstract][Full Text] [Related]
6. A case-control study of cytochrome P450 1A1, glutathione S-transferase M1, cigarette smoking and lung cancer susceptibility (Massachusetts, United States).
Garcia-Closas M; Kelsey KT; Wiencke JK; Xu X; Wain JC; Christiani DC
Cancer Causes Control; 1997 Jul; 8(4):544-53. PubMed ID: 9242469
[TBL] [Abstract][Full Text] [Related]
7. Association between cytochrome P450 1A1 (CYP1A1) gene polymorphisms and the risk of renal cell carcinoma: a meta-analysis.
Meng FD; Ma P; Sui CG; Tian X; Jiang YH
Sci Rep; 2015 Jan; 5():8108. PubMed ID: 25630554
[TBL] [Abstract][Full Text] [Related]
8. Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens.
Le Marchand L; Sivaraman L; Pierce L; Seifried A; Lum A; Wilkens LR; Lau AF
Cancer Res; 1998 Nov; 58(21):4858-63. PubMed ID: 9809991
[TBL] [Abstract][Full Text] [Related]
9. CYP1A1, GSTM1 and GSTT1 genetic polymorphisms and gastric cancer risk among Japanese: A nested case-control study within a large-scale population-based prospective study.
Hidaka A; Sasazuki S; Matsuo K; Ito H; Charvat H; Sawada N; Shimazu T; Yamaji T; Iwasaki M; Inoue M; Tsugane S;
Int J Cancer; 2016 Aug; 139(4):759-68. PubMed ID: 27062139
[TBL] [Abstract][Full Text] [Related]
10. Risk for K-ras gene mutations in smoking-induced lung cancer is associated with cytochrome P4501A1 and glutathione S-transferase micro1 polymorphisms.
Noda N; Matsuzoe D; Konno T; Kawahara K; Yamashita Y; Shirakusa T
Oncol Rep; 2004 Oct; 12(4):773-9. PubMed ID: 15375499
[TBL] [Abstract][Full Text] [Related]
11. Cigarette smoking, genetic polymorphisms and colorectal cancer risk: the Fukuoka Colorectal Cancer Study.
Nisa H; Kono S; Yin G; Toyomura K; Nagano J; Mibu R; Tanaka M; Kakeji Y; Maehara Y; Okamura T; Ikejiri K; Futami K; Maekawa T; Yasunami Y; Takenaka K; Ichimiya H; Terasaka R
BMC Cancer; 2010 Jun; 10():274. PubMed ID: 20534171
[TBL] [Abstract][Full Text] [Related]
12. Aromatic DNA adducts and polymorphisms of CYP1A1, NAT2, and GSTM1 in breast cancer.
Firozi PF; Bondy ML; Sahin AA; Chang P; Lukmanji F; Singletary ES; Hassan MM; Li D
Carcinogenesis; 2002 Feb; 23(2):301-6. PubMed ID: 11872636
[TBL] [Abstract][Full Text] [Related]
13. A population-based, case-control study of polymorphisms in carcinogen-metabolizing genes, smoking, and pancreatic adenocarcinoma risk.
Duell EJ; Holly EA; Bracci PM; Liu M; Wiencke JK; Kelsey KT
J Natl Cancer Inst; 2002 Feb; 94(4):297-306. PubMed ID: 11854392
[TBL] [Abstract][Full Text] [Related]
14. Relationship between CYP1A1 genetic polymorphisms and renal cancer in China.
Chen J; Cheng M; Yi L; Jiang CB
Asian Pac J Cancer Prev; 2011; 12(9):2163-6. PubMed ID: 22296350
[TBL] [Abstract][Full Text] [Related]
15. Possible risk modification by CYP1A1, GSTM1 and GSTT1 gene polymorphisms in lung cancer susceptibility in a South Indian population.
Sreeja L; Syamala V; Hariharan S; Madhavan J; Devan SC; Ankathil R
J Hum Genet; 2005; 50(12):618-27. PubMed ID: 16228113
[TBL] [Abstract][Full Text] [Related]
16. Cigarette smoking, cytochrome P450 1A1 polymorphisms, and breast cancer risk in the Nurses' Health Study.
Ishibe N; Hankinson SE; Colditz GA; Spiegelman D; Willett WC; Speizer FE; Kelsey KT; Hunter DJ
Cancer Res; 1998 Feb; 58(4):667-71. PubMed ID: 9485019
[TBL] [Abstract][Full Text] [Related]
17. Metabolic Phase I (CYPs) and Phase II (GSTs) Gene Polymorphisms and Their Interaction with Environmental Factors in Nasopharyngeal Cancer from the Ethnic Population of Northeast India.
Singh SA; Ghosh SK
Pathol Oncol Res; 2019 Jan; 25(1):33-44. PubMed ID: 28952035
[TBL] [Abstract][Full Text] [Related]
18. GSTM1, GSTT1 and CYP1A1 detoxification gene polymorphisms and susceptibility to smoking-related coronary artery disease: a case-only study.
Manfredi S; Federici C; Picano E; Botto N; Rizza A; Andreassi MG
Mutat Res; 2007 Aug; 621(1-2):106-12. PubMed ID: 17408703
[TBL] [Abstract][Full Text] [Related]
19. Metabolic polymorphisms, smoking, and oral cancer in Puerto Rico.
Xie H; Hou L; Shields PG; Winn DM; Gridley G; Bravo-Otero E; Diehl SR; Bowman ED; Brown LM; Hayes RB
Oncol Res; 2004; 14(6):315-20. PubMed ID: 15206494
[TBL] [Abstract][Full Text] [Related]
20. GSTM1 and CYP1A1 polymorphisms, tobacco, air pollution, and lung cancer: a study in rural Thailand.
Pisani P; Srivatanakul P; Randerson-Moor J; Vipasrinimit S; Lalitwongsa S; Unpunyo P; Bashir S; Bishop DT
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):667-74. PubMed ID: 16614107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
